Page last updated: 2024-08-16

resveratrol and vorinostat

resveratrol has been researched along with vorinostat in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (66.67)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W1
Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V1
Gray, SG1
Chen, S; Dai, Y; Dent, P; Grant, S; Hock, S; Rosato, R; Yaseen, A1
Bisen, PS; Bundela, S; Sharma, A1
Glasow, A; Kortmann, RD; Menzel, F; Patties, I1
Dwibedi, V; Kalia, S; Saxena, S1
Bai, Y; Huang, J; Huang, W; Lu, X; Shu, P; Wen, F1
Feng, Z; Gao, X; Wang, X; Xue, Y; Yang, Z1

Reviews

3 review(s) available for resveratrol and vorinostat

ArticleYear
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
    Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

    Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma

2017
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction

2022
Epigenetic treatment of neurological disease.
    Epigenomics, 2011, Volume: 3, Issue:4

    Topics: Alzheimer Disease; Butylamines; Cell Differentiation; Endoplasmic Reticulum Stress; Epigenesis, Genetic; Histone Code; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Huntington Disease; Hydroxamic Acids; Neurons; Phenylbutyrates; Protein Processing, Post-Translational; Resveratrol; Stilbenes; Valproic Acid; Vorinostat

2011

Other Studies

6 other study(ies) available for resveratrol and vorinostat

ArticleYear
Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
    Molecular pharmacology, 2012, Volume: 82, Issue:6

    Topics: Acetylation; Apoptosis; Caspase 8; Cell Line, Tumor; DNA Damage; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Leukemia, Myeloid, Acute; Metalloporphyrins; Mitochondria; NF-kappa B; Panobinostat; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; S Phase; Sirtuin 1; Stilbenes; Transcription Factor RelA; U937 Cells; Up-Regulation; Vorinostat

2012
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat

2015
Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
    Journal of experimental & clinical cancer research : CR, 2016, 06-17, Volume: 35, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Combined Modality Therapy; Decitabine; Dideoxynucleosides; Epigenesis, Genetic; Humans; Hydroxamic Acids; Medulloblastoma; Mice; Neurogenesis; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Treatment Outcome; Tretinoin; Valproic Acid; Vorinostat; Xenograft Model Antitumor Assays

2016
Isolation and enhancement of resveratrol production in Xylaria psidii by exploring the phenomenon of epigenetics: using DNA methyltransferases and histone deacetylase as epigenetic modifiers.
    Molecular biology reports, 2019, Volume: 46, Issue:4

    Topics: Azacitidine; DNA; DNA Methylation; DNA Modification Methylases; Epigenesis, Genetic; Epigenomics; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Resveratrol; Vorinostat; Xylariales

2019
Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
    Biomarkers in medicine, 2020, Volume: 14, Issue:12

    Topics: Amiodarone; Cell Cycle Proteins; Clomipramine; Collagen Type I; Databases, Genetic; Datasets as Topic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Ki-67 Antigen; Levallorphan; Microtubule-Associated Proteins; Neoplasm Proteins; Osteopontin; Piroxicam; Polo-Like Kinase 1; Procaine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Small Molecule Libraries; Stomach Neoplasms; Ursodeoxycholic Acid; Vorinostat

2020
Resveratrol Promotes HIV-1 Tat Accumulation via AKT/FOXO1 Signaling Axis and Potentiates Vorinostat to Antagonize HIV-1 Latency.
    Current HIV research, 2021, Volume: 19, Issue:3

    Topics: Anti-HIV Agents; HIV Infections; Humans; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Virus Activation; Virus Latency; Vorinostat

2021